Open access · US-GOV
via ClinicalTrials.gov Clinical trial
The Validation and Beneficial Effects of Yizhi Baduanjin for Patients With Mild Cognitive Impairment: a Pilot Randomised Controlled Trial
Authors not listed
The University of Hong Kong · 2023
Abstract
The trial is designed to examine whether Yizhi Baduanjin could slow down and improve in memory, logical thinking and cerebral function in patients with mild cognitive impairment (MCI). 30 MCI patients will be recruited and randomly assigned to Yizhi Baduanjin intervention group control group for 6 months. The primary outcome is changes in Montreal Cognitive Assessment (MoCA) questionnaire; other outcome includes Cognitive Function Assessment questionnaire.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-08 MST
Cite this
APA
Anonymous. (2023). The Validation and Beneficial Effects of Yizhi Baduanjin for Patients With Mild Cognitive Impairment: a Pilot Randomised Controlled Trial. <em>The University of Hong Kong</em>. https://clinicaltrials.gov/study/NCT06453941
Vancouver
Anonymous. The Validation and Beneficial Effects of Yizhi Baduanjin for Patients With Mild Cognitive Impairment: a Pilot Randomised Controlled Trial. The University of Hong Kong. 2023.
BibTeX
@misc{anon2023TheVal,
title = {The Validation and Beneficial Effects of Yizhi Baduanjin for Patients With Mild Cognitive Impairment: a Pilot Randomised Controlled Trial},
author = {Anonymous},
journal = {The University of Hong Kong},
year = {2023},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
University of Illinois at Urbana-Champaign 2022
Open access · US-GOV
Enhancing Quality of Life for Older Adults With and Without Mild Cognitive Impairment (MCI) Through Social Engagement Over Video Technology
NVP Healthcare 2026
Open access · US-GOV
36-week, Single-center, Randomized, Double-blind, Parallel-design, Placebo-controlled Trial to Determine the Safety and Efficacy of NVP-NK4146 in Patients With Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease
The Hong Kong Polytechnic University 2025
Open access · US-GOV
Effects of Music-with-Movement (Simultaneous Cognitive-motor Dual-task Training) on Cognitive and Physical Performance of People With Potentially Reversible Cognitive Frailty: a Randomised Controlled Trial
Novartis 2003
Open access · US-GOV
Efficacy and Safety of Rivastigmine in Patients With Mild Cognitive Impairment
Johns Hopkins University 2009
Open access · US-GOV
Bridging Cognitive Aging in Rodents to Man Using fMRI in Amnestic MCI
Assistance Publique - Hôpitaux de Paris 2007
Open access · US-GOV